Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome of second-line chemotherapy for biliary tract cancer.
Bridgewater J, Palmer D, Cunningham D, Iveson T, Gillmore R, Waters J, Harrison M, Wasan H, Corrie P, Valle J. Bridgewater J, et al. Among authors: cunningham d. Eur J Cancer. 2013 Apr;49(6):1511. doi: 10.1016/j.ejca.2012.11.024. Epub 2012 Dec 20. Eur J Cancer. 2013. PMID: 23265701 No abstract available.
Colorectal cancer.
Waters JS, Cunningham D. Waters JS, et al. Among authors: cunningham d. Lancet. 1999 Mar 20;353(9157):1012-3. doi: 10.1016/S0140-6736(05)70721-2. Lancet. 1999. PMID: 10459935 No abstract available.
Adjuvant chemotherapy.
Waters JS, Cunningham D. Waters JS, et al. Among authors: cunningham d. Lancet. 2000 Oct 7;356(9237):1276. doi: 10.1016/S0140-6736(05)73882-4. Lancet. 2000. PMID: 11072976 No abstract available.
The changing face of chemotherapy in colorectal cancer.
Waters J, Cunningham D. Waters J, et al. Among authors: cunningham d. Br J Cancer. 2001 Jan 5;84(1):1-7. doi: 10.1054/bjoc.2000.1552. Br J Cancer. 2001. PMID: 11139304 Free PMC article. Review. No abstract available.
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.
Ross P, Nicolson M, Cunningham D, Valle J, Seymour M, Harper P, Price T, Anderson H, Iveson T, Hickish T, Lofts F, Norman A. Ross P, et al. Among authors: cunningham d. J Clin Oncol. 2002 Apr 15;20(8):1996-2004. doi: 10.1200/JCO.2002.08.105. J Clin Oncol. 2002. PMID: 11956258 Clinical Trial.
Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer.
Saini A, Norman AR, Cunningham D, Chau I, Hill M, Tait D, Hickish T, Iveson T, Lofts F, Jodrell D, Ross PJ, Oates J. Saini A, et al. Among authors: cunningham d. Br J Cancer. 2003 Jun 16;88(12):1859-65. doi: 10.1038/sj.bjc.6600995. Br J Cancer. 2003. PMID: 12799627 Free PMC article. Clinical Trial.
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF.
Sumpter K, Harper-Wynne C, Cunningham D, Rao S, Tebbutt N, Norman AR, Ward C, Iveson T, Nicolson M, Hickish T, Hill M, Oates J. Sumpter K, et al. Among authors: cunningham d. Br J Cancer. 2005 Jun 6;92(11):1976-83. doi: 10.1038/sj.bjc.6602572. Br J Cancer. 2005. PMID: 15928658 Free PMC article. Clinical Trial.
2,235 results